Determinants of costs and benefits in atopic dermatitis routine care in Germany

The economic burden of atopic dermatitis (AD) is of particular interest. The present study aims to analyse the association of disease‐related characteristics, annual costs and treatment benefits in AD.

[1]  N. Mohr,et al.  Adherence to Guideline-Oriented Preventive Measures in Patients with Atopic Dermatitis in Germany , 2021, Dermatology.

[2]  R. Sommer,et al.  Mapping risk factors for cumulative life course impairment in patients with chronic skin diseases – a systematic review , 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  T. Agner,et al.  Childhood atopic dermatitis is associated with a decreased chance of completing education later in life: a register‐based cohort study , 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

[4]  T. Bieber,et al.  Cost‐of‐illness of atopic dermatitis in Germany: data from dermatology routine care , 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  M. Augustin,et al.  Determinants of costs and benefits in psoriasis routine care: results from a cross‐sectional nationwide study in Germany , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  T. Werfel,et al.  The show must go on: an update on clinical experiences and clinical studies on novel pharmaceutical developments for the treatment of atopic dermatitis. , 2020, Current opinion in allergy and clinical immunology.

[7]  H. Murota,et al.  Cost of illness study for adult atopic dermatitis in Japan: A cross‐sectional Web‐based survey , 2020, The Journal of dermatology.

[8]  Lorena Estrada-Aguilar,et al.  Costo anual de la atención médica de pacientes con dermatitis atópica moderada a grave en México. Estudio multicéntrico , 2020 .

[9]  K. Peris,et al.  The burden of atopic dermatitis in adults in Italy. , 2020, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[10]  M. Augustin,et al.  Atopic dermatitis shows significant cutaneous comorbidity: results from large‐scale investigations in the working population , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  H. van Os-Medendorp,et al.  Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment. , 2019, Acta dermato-venereologica.

[12]  D. Margolis,et al.  Atopic Dermatitis in US Adults: From Population to Health Care Utilization. , 2019, The journal of allergy and clinical immunology. In practice.

[13]  J. Silverberg,et al.  Epidemiology of adult atopic dermatitis. , 2018, Clinics in dermatology.

[14]  J. Ring,et al.  Measurement of healthcare quality in atopic dermatitis – development and application of a set of quality indicators , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[15]  A. Muraro,et al.  Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[16]  D. Margolis,et al.  Epidemiology of atopic dermatitis in adults: Results from an international survey , 2018, Allergy.

[17]  A. Muraro,et al.  Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[18]  K. Schäkel,et al.  Effects of structured patient education in adults with atopic dermatitis: Multicenter randomized controlled trial , 2017, The Journal of allergy and clinical immunology.

[19]  M. Augustin,et al.  Prevalence and comorbidities in adults with psoriasis compared to atopic eczema , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[20]  S. Nutten.  Atopic Dermatitis: Global Epidemiology and Risk Factors , 2015, Annals of Nutrition and Metabolism.

[21]  M. Augustin,et al.  The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases , 2009, Archives of Dermatological Research.